A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Clinical trial NCT06736613 · RECRUITING

Trial details

NCT number: NCT06736613
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma High-grade B-cell Lymphoma Stage III High Grade B-Cell Lymphoma Stage IV High Grade B-Cell Lymphoma DLBCL - Diffuse Large B Cell Lymphoma Intravascular Large B-Cell Lymphoma Diffuse Large B Cell Lymphoma of Breast Diffuse Large B Cell Lymphoma of Testis HIV-associated Diffuse Large B Cell Lymphoma Double Expressor DLBCL

Start date: 2024-12-11
Primary completion: 2027-12-11
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.